EXOSOME ENTHALTEND THERAPEUTISCHE POLYPEPTIDE

Patent europeic · EP3782646 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP3782646
Numer da la dumonda
EP20201528
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
25-05-2017
Publitgà
24-02-2021
Concedì
25-09-2024
Stritgà
23-12-2025
Motiv
Taxa annuala betg pajada
Classas IPC
A61K 38/00 (2006.01)
A61K 41/00 (2020.01)
A61K 47/65 (2017.01)
A61K 47/64 (2017.01)
A61K 47/69 (2017.01)
Prioritad
GB 201609216 25.05.2016
Derivà da
EP17727325
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 23-12-2025

    Stritgà, taxa betg pajada

    Status of protective title
    Active → Cancelled
    Cancellation date
    23.12.2025
    Cause for cancellation
    Non-payment of renewal fee

    Published in Swissreg on 23.12.2025

  2. 06-08-2025

    Midada

    Published in Swissreg on 06.08.2025

  3. 25-09-2024

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 25.09.2024

Partidas

Possessur

Evox Therapeutics Limited

Oxford Science Park Medawar Centre 2nd Floor East Building Robert Robinson Avenue, Oxford, Oxfordshire OX4 4HG, GB

Oxford University Innovation

Buxton Court 3 West Way, Oxford OX2 0JB, GB

Inventur

HEAN, Justin

Oxford, Oxfordshire OX2 7SS, GB

MAGER, Imre

Oxford OX1 2JD, GB

WOOD, Matthew

Oxford, Oxfordshire OX2 6HY, GB

EL ANDALOUSSI, Samir

14131 Huddinge, SE

WIKLANDER, Oscar

Huddinge 141 57, SE

NORDIN, Joel

11762 Stockholm, SE

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.